IRVINE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NYMXF) [OTC Markets – NYMXF] (the “Company”) is pleased to announce today that a new formal submission has been ...

TORONTO, Nov. 28, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF) (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets ...

Benign prostatic hyperplasia (BPH) is a non-cancerous prostate tissue growth affecting men 40 and older. BPH can cause difficulty urinating and may be exacerbated by some cold and allergy medications.

This story is sponsored by Revere Health. Holmium Laser Enucleation of the Prostate (HoLEP) is rapidly becoming the gold standard surgical treatment for benign prostatic hyperplasia (BPH), and there ...

Vipul R. Patel, MD, FACS, is a board-certified urologic surgeon, medical director of the Global Robotics Institute at AdventHealth, and medical director of urologic oncology at AdventHealth Cancer ...

An enlarged prostate, known as benign prostatic hyperplasia (BPH), is a common condition often associated with the natural aging process in men. Dr. Scott Cheney, a Mayo Clinic urologist, says it's a ...

Driven by a growing patient population, rapid adoption of minimally invasive and robotic technologies, increased use of diagnostic-guided focal therapies, and the ongoing dominance of proven ...